...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: New Share Price Contest

"Bear - Sorry, this was said and three persons have now posted that they heard it. Your challenge that we must supply a transcript or such was overly onerus as Q&A's and casual post-presentation banter at the podium are not included in their transcripts. I have already checked the Link Library for last Fall's AGM and no Q&A."

Fine. It is possible that ~2000 patients across ~14 countries around the world and across hundreds of individual study sites all coincidentally with no prior coordination simultaneously initiated a request to their individual doctor and/or study site/country lead investigator. Upon receiving an unsolicited, unanticipated and unanimous request from all BETonMACE patients, Resverlogix decided that they'd better amend their BETonMACE trial protocol to accommodate the wishes of the clinical trial study patients. I mean, why follow a pre-determined clinical trial protocol arrived at by thorough discussions amongst Resverlgoix, the clinical steering committee, regulatory agencies, etc. Why not just have the patients design the clinical trial. The patient is always right, right? Quite amazing, if true. Maybe there's a BETonMACE facebook group......MACEbook. Or, maybe the likelihood of the above is near nil and instead Resverlogix and Clinical Steering Committee were the ones with the great idea to amend the BETonMACE protocol and offer this option to patients. Nah....it must have been the patients.

BDAZ

Share
New Message
Please login to post a reply